Related Experiment Video

Updated: Aug 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Elevated serum uric acid. A cardiovascular risk factor?

M G Tweeddale, J G Fodor

    Nephron
    |January 1, 1979
    PubMed

    Insights

    Elevated serum uric acid is linked to hypertension, potentially as an independent risk factor. Its role in ischemic heart disease is debated, possibly influenced by the uric acid-hypertension relationship.

    Area of Science:

    • Nephrology
    • Cardiology
    • Metabolic Disorders

    Background:

    • Elevated serum uric acid is associated with hypertension.
    • The independent risk factor role of uric acid in ischemic heart disease is controversial.
    • Uric acid's metabolic turnover in hypertensive individuals is not well-defined.

    Purpose of the Study:

    • To critically survey the literature on the association between serum uric acid and hypertension.
    • To evaluate the controversial role of uric acid as an independent risk factor for ischemic heart disease.
    • To explore the mechanisms of elevated uric acid during diuretic treatment.

    Main Methods:

    • Literature review and critical analysis of existing studies.
    • Examination of the relationship between uric acid levels and hypertension.
    • Investigation into the potential link between uric acid and ischemic heart disease.
    • Analysis of factors contributing to elevated uric acid in patients on diuretic therapy.

    Main Results:

    • A definite association exists between elevated serum uric acid and hypertension.
    • Elevated uric acid may be an independent risk factor for hypertension.
    • The link between uric acid and ischemic heart disease is debated and may be mediated by hypertension.
    • Diuretic-induced extracellular volume depletion is an initial factor in elevated uric acid during treatment.

    Conclusions:

    • Elevated serum uric acid is strongly linked to hypertension and may be an independent risk factor.
    • Further research is needed to clarify the role of uric acid in ischemic heart disease.
    • Understanding uric acid metabolism in hypertension and diuretic use requires further investigation.

    Related Concept Videos

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Serum Studies: Renal Function Tests01:24

    Serum Studies: Renal Function Tests

    Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.